A conference of international advisers has been held in the frames of the Hepatitis C Elimination Program of Georgia. The international partners will support and carry out consultations for implementing long-term strategies in monitoring, prevention and controlling systems.
The International Advisory Group, whose members are the heads of the US Center for Disease Control and Prevention, Emory and Hopkins Universities, World Health Organization and other international partners, attended the conference. They aim to encourage development of Hepatitis C elimination and also to increase public awareness.
The results of the Hepatitis C Elimination Program and its current conditions were discussed. According to the Ministry of Healthcare, 130-150 million people suffer from Hepatitis C and, in the WHO’s criteria, Georgia is considered as a high-prevalence country
Labels: Country of Georgia, Hepatitis C Elimination Program, Sofosbuvir, World Health Organization